+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

ESCMID LMIC Grant

ESCMID

For ESCMID Global 2026, we will fund the LMIC grant to LMIC members regardless of age and career level. This Grant does not require a prerequisite of submitting an abstract. The LMIC Grant covers the ESCMID Global registration fee and an allowance of up to 1.3K EUR (€) for travel and accommodation costs.

Funding

The LMIC Grant covers the congress registration fee and offers a substantial travel allowance of up to 1.3K EUR (€) to help offset the travel and accommodation costs of attending ESCMID Global on site. It is important to note that the travel allowance is exclusively available to awardees who participate onsite. If awardees cannot join us onsite, they can still benefit from the free registration.

Application process

Applications can be made through the link on this webpage while the call for applications is open. Applicant must submit a short motivational letter (up to 500 words) and proof of residence in LMIC.

Selection and notification

Grant applications will undergo an eligibility check and careful evaluation by the ESCMID team. Notifications regarding the outcome of the grant selection process are sent in December. For those selected as a grant recipient, your name may be showcased on the ESCMID Global official website and featured in esteemed ESCMID publications.

AI Based Application Success Predictor

1. High disease burden & global relevance

Winning proposals clearly justify:

High morbidity/mortality conditions

Public health importance

Antimicrobial resistance (AMR) implications

Emerging pathogens

Avoid niche topics without prevalence justification.

2. Explicit clinical translation

Projects with a direct route to:

diagnostics

therapeutic decision-making

surveillance improvements

patient outcomes

Mechanistic-only without clinical relevance scores weaker.

3. Integration of antimicrobial stewardship

Applicants successful in the past:

address misuse/overuse

propose optimization strategies

target resistance drivers

ESCMID sees stewardship as mission-critical.

4. Feasibility supported by preliminary data

Highly predictive elements:

pilot isolates/samples already collected

proof-of-concept molecular workflows

established biobanking

validated protocols

Reviewer skepticism declines with even minimal pilot evidence.

5. Multidisciplinary collaboration

Strengthens scores when teams span:

clinical infectious diseases

microbiology labs

epidemiology/data science

pharmacology

Single-discipline = weaker competitiveness.

6. Geographic diversity & international cooperation

ESCMID strongly values:

EU–non-EU collaboration

low- and middle-income country partnerships

global surveillance networks

These broaden impact scores.

7. Practical outputs within grant duration

Reviewers prefer deliverables such as:

validated diagnostic assay

resistance gene catalog

stewardship algorithm

surveillance datasets

Too theoretical = flagged.

8. Methodological rigor

Funded proposals commonly show:

properly powered sample sizes

robust statistics consultation

standardized culture/PCR/sequencing protocols

clear inclusion/exclusion criteria

Weak design → automatic downgrades.

🧫 Favorable Research Themes (Portfolio Trend)

Awardees frequently propose work in:

antimicrobial resistance (AMR) evolution

hospital-acquired infections

rapid diagnostic technologies

carbapenem-resistant Enterobacterales

tuberculosis & HIV co-infection

SARS-CoV-2 and post-pandemic surveillance

fungal infections (Candida auris, Aspergillus)

🧠 Applicant Track Record Predictors

Successful profiles often include:

3–10 relevant peer-reviewed publications

poster/podium presentations at ECCMID

local microbiology/infectious diseases involvement

mentorship history

Trajectory is more important than volume.

🏛️ Institutional Strength Predictors

Awardees often have access to:

CLIA/ISO-accredited microbiology labs

sequencing core facilities

antibiotic susceptibility testing infrastructure

biostatistics support

Institutional capacity matters.

🧪 Methods That Score Well

Consistently strong signals:

Whole genome sequencing (WGS)

Metagenomics

Resistance gene profiling

Novel point-of-care diagnostics

Infection modeling

AI risk prediction tools

📉 Common Reviewer Criticisms

Patterns repeatedly seen in unsuccessful proposals:

unclear clinical endpoint relevance

inadequate statistical justification

no risk mitigation (e.g., low recruitment)

overly broad aims

weak stewardship component

limited feasibility in timeframe

💥 Red Flags

✘ purely basic immunology without infection context
✘ no antimicrobial resistance angle
✘ no patient applicability
✘ unrealistic recruitment
✘ vague deliverables

🔁 For travel grants & observerships

Strong predictors include:

clearly justified learning objectives

match between host lab expertise & applicant’s CV

institutional endorsement

plan to implement new competency back home

“Tourism-style” proposals are rejected immediately.

🧬 For Young Investigator Awards

Reviewers look for:

early signs of leadership

independent micro-project ideas

theme continuity

first-author publications

clear mentorship structure

🧵 Meta-Pattern

Successful ESCMID applications demonstrate:

✅ Clinical microbiology relevance
✅ Antimicrobial resistance strategy
✅ Solid feasibility/pilot evidence
✅ Translational potential & patient application
✅ Statistical rigor
✅ Global health awareness
✅ Interdisciplinary collaboration

Applications lacking any of these tend to underperform.

✅ Summary

You are more likely to win ESCMID funding if your project:

Addresses high-burden infectious disease

Includes stewardship / AMR relevance

Demonstrates feasibility with pilot data

Has real-world diagnostic or patient outcome translation

Uses up-to-date methods (WGS, metagenomics, AI)

Shows institutional laboratory strength

Includes realistic, measurable milestones

Specialties

Infectious Diseases

Microbiology

Eligibility Requirements

ESCMID encourages you to apply for the LMIC Grant if you meet the criteria below:

You live and work in an LMIC
You are an ESCMID LMIC Member

Sponsor Details

Sponsor Institute/Organizations: ESCMID

Sponsor Type: Corporate/Non-Profit

Address: Aeschenvorstadt 55 4051 Basel SWITZERLAND

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity